Table 4.
Correlation analysis for the association of TMAO with clinical parameters in CHD and CHD-T2DM patients.
| Cardiovascular risk factors | TMAO | |||
|---|---|---|---|---|
| CHD | CHD-T2DM | |||
| Coefficient | P value | Coefficient | P value | |
| HDL | 0.174 | 0.001 | 0.167 | 0.006 |
| LDL | 0.009 | 0.865 | 0.006 | 0.920 |
| Total cholesterol | 0.145 | 0.006 | 0.018 | 0.759 |
| Triglyceride | 0.038 | 0.472 | 0.182 | 0.002 |
| Lipoprotein (a) | 0.034 | 0.525 | 0.109 | 0.072 |
| Lipoprotein (b) | 0.189 | 0.001 | 0.080 | 0.186 |
| Blood glucose | 0.031 | 0.564 | 0.176 | 0.003 |
| hs-TnI | 0.127 | 0.052 | 0.221 | 0.001 |
| CKMB | 0.125 | 0.034 | 0.216 | 0.001 |